Literature DB >> 20631994

Ventral and dorsal striatal dopamine efflux and behavior in rats with simple vs. co-morbid histories of cocaine sensitization and neonatal ventral hippocampal lesions.

Robert Andrew Chambers1, Alena M Sentir, Eric A Engleman.   

Abstract

RATIONAL: Exposing animal models of mental illness to addictive drugs provides an approach to understanding the neural etiology of dual diagnosis disorders. Previous studies have shown that neonatal ventral hippocampal lesions (NVHL) in rats produce features of both schizophrenia and addiction vulnerability.
OBJECTIVE: This study investigated ventral and dorsal striatal dopamine (DA) efflux in NVHL rats combined with behavioral sensitization to cocaine.
METHODS: Adult NVHL vs. SHAM-operated rats underwent a 5-day injection series of cocaine (15 mg/kg/day) vs. saline. One week later, rats were cannulated in nucleus accumbens SHELL, CORE, or caudate-putamen. Another week later, in vivo microdialysis sampled DA during locomotor testing in which a single cocaine injection (15 mg/kg) was delivered.
RESULTS: NVHLs and cocaine history significantly increased behavioral activation approximately 2-fold over SHAM-saline history rats. DA efflux curves corresponded time dependently with the cocaine injection and locomotor curves and varied significantly by striatal region: Baseline DA levels increased 5-fold while cocaine-stimulated DA efflux decreased by half across a ventral to dorsal striatal gradient. However, NVHLs, prior cocaine history, and individual differences in behavior were not underpinned by differential DA efflux overall or within any striatal region.
CONCLUSION: Differences in ventral/dorsal striatal DA efflux are not present in and are not required for producing differential levels of acute cocaine-induced behavioral activation in NVHLs with and without a behaviorally sensitizing cocaine history. These findings suggest other neurotransmitter systems, and alterations in striatal network function post-synaptic to DA transmission are more important to understanding the interactive effects of addictive drugs and mental illness.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20631994      PMCID: PMC2921051          DOI: 10.1007/s00213-010-1929-1

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  43 in total

1.  Psychostimulant sensitization: differential changes in accumbal shell and core dopamine.

Authors:  C Cadoni; M Solinas; G Di Chiara
Journal:  Eur J Pharmacol       Date:  2000-01-24       Impact factor: 4.432

Review 2.  Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies.

Authors:  L J Vanderschuren; P W Kalivas
Journal:  Psychopharmacology (Berl)       Date:  2000-08       Impact factor: 4.530

3.  Motivational responses to natural and drug rewards in rats with neonatal ventral hippocampal lesions: an animal model of dual diagnosis schizophrenia.

Authors:  R Andrew Chambers; David W Self
Journal:  Neuropsychopharmacology       Date:  2002-12       Impact factor: 7.853

4.  Attenuated extracellular dopamine levels after stress and amphetamine in the nucleus accumbens of rats with neonatal ventral hippocampal damage.

Authors:  S M Lillrank; B K Lipska; B S Kolachana; D R Weinberger
Journal:  J Neural Transm (Vienna)       Date:  1999       Impact factor: 3.575

5.  Post-pubertal disruption of medial prefrontal cortical dopamine-glutamate interactions in a developmental animal model of schizophrenia.

Authors:  Kuei-Yuan Tseng; Barbara L Lewis; Barbara K Lipska; Patricio O'Donnell
Journal:  Biol Psychiatry       Date:  2007-01-03       Impact factor: 13.382

Review 6.  Synaptic plasticity and addiction.

Authors:  Julie A Kauer; Robert C Malenka
Journal:  Nat Rev Neurosci       Date:  2007-11       Impact factor: 34.870

7.  Role of extracellular dopamine in the initiation and long-term expression of behavioral sensitization to cocaine.

Authors:  C A Heidbreder; A C Thompson; T S Shippenberg
Journal:  J Pharmacol Exp Ther       Date:  1996-08       Impact factor: 4.030

8.  Neonatal ventral hippocampal lesions attenuate the nucleus accumbens dopamine response to stress: an electrochemical study in the adult rat.

Authors:  W G Brake; R M Sullivan; G Flores; L K Srivastava; A Gratton
Journal:  Brain Res       Date:  1999-06-12       Impact factor: 3.252

9.  GABAergic modulation of the 40 Hz auditory steady-state response in a rat model of schizophrenia.

Authors:  Jenifer L Vohs; R Andrew Chambers; Giri P Krishnan; Brian F O'Donnell; Sarah Berg; Sandra L Morzorati
Journal:  Int J Neuropsychopharmacol       Date:  2009-07-23       Impact factor: 5.176

10.  Ethanol and negative feedback regulation of mesolimbic dopamine release in rats.

Authors:  R R Kohl; J S Katner; E Chernet; W J McBride
Journal:  Psychopharmacology (Berl)       Date:  1998-09       Impact factor: 4.530

View more
  12 in total

1.  Chronic administration of the neurotrophic agent cerebrolysin ameliorates the behavioral and morphological changes induced by neonatal ventral hippocampus lesion in a rat model of schizophrenia.

Authors:  Rubén Antonio Vázquez-Roque; Brenda Ramos; Carolina Tecuatl; Ismael Juárez; Anthony Adame; Fidel de la Cruz; Sergio Zamudio; Raúl Mena; Edward Rockenstein; Eliezer Masliah; Gonzalo Flores
Journal:  J Neurosci Res       Date:  2011-09-19       Impact factor: 4.164

2.  Attenuation of cocaine-induced conditioned locomotion is associated with altered expression of hippocampal glutamate receptors in mice lacking LPA1 receptors.

Authors:  Eduardo Blanco; Ainhoa Bilbao; María Jesús Luque-Rojas; Ana Palomino; Francisco J Bermúdez-Silva; Juan Suárez; Luis J Santín; Guillermo Estivill-Torrús; Antonia Gutiérrez; José Angel Campos-Sandoval; Francisco J Alonso-Carrión; Javier Márquez; Fernando Rodríguez de Fonseca
Journal:  Psychopharmacology (Berl)       Date:  2011-09-02       Impact factor: 4.530

3.  Correlation between hippocampal sulcus width and severity of obstructive sleep apnea syndrome.

Authors:  Galip Akhan; Murat Songu; Sibel Oktem Ayik; Canan Altay; Serdar Kalemci
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-12-11       Impact factor: 2.503

Review 4.  The link between schizophrenia and substance use disorder: A unifying hypothesis.

Authors:  Jibran Y Khokhar; Lucas L Dwiel; Angela M Henricks; Wilder T Doucette; Alan I Green
Journal:  Schizophr Res       Date:  2017-04-14       Impact factor: 4.939

5.  Cortical-striatal gene expression in neonatal hippocampal lesion (NVHL)-amplified cocaine sensitization.

Authors:  R A Chambers; J N McClintick; A M Sentir; S A Berg; M Runyan; K H Choi; H J Edenberg
Journal:  Genes Brain Behav       Date:  2013-06-22       Impact factor: 3.449

6.  Selective effects of D- and L-govadine in preclinical tests of positive, negative, and cognitive symptoms of schizophrenia.

Authors:  Christopher C Lapish; Kee-Chan Ahn; R Andrew Chambers; Donovan M Ashby; Soyon Ahn; Anthony G Phillips
Journal:  Neuropsychopharmacology       Date:  2014-01-30       Impact factor: 7.853

7.  Identification and distribution of projections from monoaminergic and cholinergic nuclei to functionally differentiated subregions of prefrontal cortex.

Authors:  Daniel J Chandler; Carolyn S Lamperski; Barry D Waterhouse
Journal:  Brain Res       Date:  2013-05-07       Impact factor: 3.252

Review 8.  Schizophrenia: an integrated sociodevelopmental-cognitive model.

Authors:  Oliver D Howes; Robin M Murray
Journal:  Lancet       Date:  2013-12-06       Impact factor: 79.321

Review 9.  Amphetamine-induced psychosis--a separate diagnostic entity or primary psychosis triggered in the vulnerable?

Authors:  Jørgen G Bramness; Øystein Hoel Gundersen; Joar Guterstam; Eline Borger Rognli; Maija Konstenius; Else-Marie Løberg; Sigrid Medhus; Lars Tanum; Johan Franck
Journal:  BMC Psychiatry       Date:  2012-12-05       Impact factor: 3.630

10.  Nicotine is more addictive, not more cognitively therapeutic in a neurodevelopmental model of schizophrenia produced by neonatal ventral hippocampal lesions.

Authors:  Sarah A Berg; Alena M Sentir; Benjamin S Cooley; Eric A Engleman; R Andrew Chambers
Journal:  Addict Biol       Date:  2013-08-06       Impact factor: 4.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.